Childress Capital Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.64M Sell
21,942
-877
-4% -$101K 0.48% 36
2025
Q4
$2.4M Buy
22,819
+9,529
+72% +$894K 0.39% 46
2025
Q3
$1.12M Buy
13,290
+1,062
+9% +$87.5K 0.2% 81
2025
Q2
$968K Buy
12,228
+2,065
+20% +$164K 0.24% 67
2025
Q1
$912K Sell
10,163
-675
-6% -$63K 0.26% 59
2024
Q4
$1.08M Sell
10,838
-1,540
-12% -$159K 0.3% 56
2024
Q3
$1.41M Buy
12,378
+62
+0.5% +$7.37K 0.38% 46
2024
Q2
$1.52M Buy
12,316
+1,325
+12% +$171K 0.43% 40
2024
Q1
$1.45M Sell
10,991
-407
-4% -$50.2K 0.42% 46
2023
Q4
$1.24M Buy
11,398
+88
+0.8% +$9.13K 0.37% 47
2023
Q3
$1.16M Buy
11,310
+9,374
+484% +$1.01M 0.38% 47
2023
Q2
$223K Sell
1,936
-3,060
-61% -$347K 0.09% 67
2023
Q1
$532K Sell
4,996
-5,440
-52% -$587K 0.23% 48
2022
Q4
$1.16M Buy
10,436
+326
+3% +$33.3K 0.38% 47
2022
Q3
$890K Sell
10,110
-318
-3% -$28.4K 0.35% 55
2022
Q2
$951K Buy
10,428
+638
+7% +$56.6K 0.38% 52
2022
Q1
$802K Buy
9,790
+779
+9% +$61.4K 0.28% 68
2021
Q4
$691K Sell
9,011
-2,372
-21% -$189K 0.29% 68
2021
Q3
$844K Buy
11,383
+4,309
+61% +$328K 0.34% 61
2021
Q2
$550K Sell
7,074
-2,247
-24% -$167K 0.25% 66
2021
Q1
$685K Buy
9,321
+2,351
+34% +$173K 0.31% 57
2020
Q4
$544K Buy
+6,970
New +$533K 0.32% 38

Other funds holding MRK

Childress Capital Advisors's MRK Position: Q1 2026 in Review

Childress Capital Advisors reduced its Merck (MRK) stake by 3.8% in Q1 2026, selling an estimated $101K and leaving 21,942 shares worth $2.64M. The position accounts for 0.48% of the portfolio, ranked #36.

Childress Capital Advisors first reported a position in MRK in Q4 2020 and has held it in 22 quarters since. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Childress Capital Advisors held 21,942 shares of Merck worth $2.64M as of Q1 2026.
  • Childress Capital Advisors sold 877 Merck shares in Q1 2026, an estimated $101K.
  • Merck made up 0.48% of Childress Capital Advisors's portfolio in Q1 2026, its #36 holding.
  • Childress Capital Advisors first reported a position in Merck in Q4 2020 and has held it in 22 quarters since.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Childress Capital Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.